Concepedia

Julia Salih

JS

Statistics

Publications

4

Citations

231

H-Index

4

Active since

2009

Affiliations

University of Tübingen(Current)

Julia Salih is an author at University of Tübingen specializing in pharmacology, interferon gamma production, and cancer immunology.

Publications per year

2009–2018

4

Publications

4

The BCR/ABL‐inhibitors imatinib, nilotinib and dasatinib differentially affect NK cell reactivity

Julia Salih, Julia Hilpert, Theresa Placke et al. · International Journal of Cancer · 2010 · 91 citations · Full text

, , +17

The Kinase Inhibitors Sunitinib and Sorafenib Differentially Affect NK Cell Antitumor Reactivity In Vitro

Matthias Krusch, Julia Salih, Manuela Schlicke et al. · The Journal of Immunology · 2009 · 89 citations · Full text

, , +16

The immune inhibitory receptor osteoactivin is upregulated in monocyte-derived dendritic cells by BCR–ABL tyrosine kinase inhibitors

Mark‐Alexander Schwarzbich, Michael Gutknecht, Julia Salih et al. · Cancer Immunology Immunotherapy · 2011 · 40 citations · Full text

, , +11

The BCR-ABL inhibitor nilotinib influences phenotype and function of monocyte-derived human dendritic cells

Daniela Dörfel, Christian Lechner, Simone Joas et al. · Cancer Immunology Immunotherapy · 2018 · 11 citations · Full text

, , +13

1–4 of 4